Latest oppositions filed by Generics Uk

This table presents recent patent oppositions filed by Generics Uk against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3999643Methods Of Treating Or Preventing Spinal Muscular AtrophyBIOGEN MA INC.Aug 21, 2024
EP3782612Oral Formulations Of Cytidine Analogs And Methods Of Use ThereofCELGENE CORPORATIONAug 8, 2024
EP3263106Method For Suppressing Bitterness Of Quinoline DerivativeEISAI R&D MANAGEMENT CO., LTD.Jul 25, 2024
EP3626270New UseNOVARTIS AGJul 11, 2024
EP3542790Compositions Comprising A Delivery Agent And Preparation ThereofNOVO NORDISK A/SJun 13, 2024
EP3650019Fluticasone Furoate In The Treatment Of CopdGLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITEDJun 6, 2024
EP3630164Dulaglutide For The Treatment Of Chronic Kidney DiseaseELI LILLY AND COMPANYMay 23, 2024
EP3352757Administration Of Deuterated Cftr PotentiatorsVERTEX PHARMACEUTICALS (EUROPE) LIMITEDMay 16, 2024
EP3110449Medical Use Of A Dpp-4 InhibitorBOEHRINGER INGELHEIM INTERNATIONAL GMBHMar 28, 2024
EP3925607Pharmaceutical Compositions For The Treatment Of Cystic Fibrosis Transmembrane Conductance Regulator Mediated DiseasesVERTEX PHARMACEUTICALS INCORPORATEDMar 28, 2024